Additional file 1: of Data-driven identification of endophenotypes of Alzheimerâ s disease progression: implications for clinical trials and therapeutic interventions

Nophar Geifman (Contributor)
Richard E. Kennedy (Creator)
Lon S. Schneider (Creator)
Iain Buchan (Creator)
Roberta Brinton (Creator)
Lon S. Schneider (Creator)
Iain Buchan (Creator)

Dataset

Description

Full list of drug groups and search terms used to evaluate medication use at baseline (XLSX 42 kb)

Date made available	2018
Publisher	figshare

DOI
10.6084/m9.figshare.5826750

Access Dataset

Creative Commons Attribution 4.0 International

1 Article

Data-driven identification of endophenotypes of Alzheimer's disease progression: Implications for clinical trials and therapeutic interventions
Geifman, N., Kennedy, R. E., Schneider, L. S., Buchan, I. & Brinton, R. D., Jan 15 2018, In: Alzheimer's Research and Therapy. 10, 1
Research output: Contribution to journal › Article › peer-review

Open Access
30 Scopus citations

Cite this

Geifman, N. (Contributor), Kennedy, R. E. (Creator), Schneider, L. S. (Creator), Buchan, I. (Creator), Brinton, R. D. (Creator), Schneider, L. (Creator), Buchan, I. (Creator) (2018). Additional file 1: of Data-driven identification of endophenotypes of Alzheimerâ s disease progression: implications for clinical trials and therapeutic interventions. figshare. 10.6084/m9.figshare.5826750

Additional file 1: of Data-driven identification of endophenotypes of Alzheimerâ s disease progression: implications for clinical trials and therapeutic interventions

Description

DOI

Access Dataset

Research output

Data-driven identification of endophenotypes of Alzheimer's disease progression: Implications for clinical trials and therapeutic interventions

Cite this